• Clathrin-Mediated GCRV Entry: Dynasore Evidence

  2026-08-19

  Wang et al. used pharmacological inhibition, transmission electron microscopy, and RT-qPCR to show that genotype III grass carp reovirus enters CIK cells through a dynamin-dependent, clathrin-mediated, acidified endosomal route. The study also distinguishes the replication kinetics of GCRV104 from genotype I GCRV-JX01 and identifies PI3K- and PKC-associated signaling as additional intervention points.

• VP26, MYH9, and Duck Enteritis Virus Replication

  2026-08-19

  A 2025 study used VP26 affinity purification and proteomics to identify host cytoskeletal proteins associated with duck enteritis virus, then validated MYH9 as a key interaction partner. Functional inhibition of actin polymerization or myosin II activity reduced viral titers, positioning the actin–myosin II network as an important host determinant of DEV proliferation.

• 5-Azacytidine Beyond Demethylation: A Translational Playbook

  2026-08-18

  5-Azacytidine is more than a DNA methylation tool: its value increasingly depends on cellular context, chromatin state, and immune competence. This thought-leadership guide connects DNMT trapping to viral mimicry, experimental design, and translational decision-making, with practical guidance for using 5-AzaC in cancer biology workflows.

• β-Pseudouridine in saRNA Assay Design

  2026-08-18

  β-Pseudouridine is the C-glycoside isomer of uridine with important implications for RNA modification research. This guide separates nucleoside chemistry from platform-level vaccine evidence and provides a practical framework for interpreting saRNA, mRNA, and translational assays.

• H. pylori–HNF4A Methylation Drives Gastric Cancer

  2026-08-17

  The reference study identifies promoter hypermethylation of HNF4A as a mechanistic link between Helicobacter pylori infection and gastric cancer progression. Its integrated clinical, single-cell, cellular, animal, methylation, and rescue analyses connect HNF4A silencing with epithelial polarity loss and TGFβ-associated EMT signaling, providing a framework for studying infection-driven epigenetic transformation.

• Valemetostat BA4816 for Reliable Cell Assays

  2026-08-17

  This scenario-based guide explains how Valemetostat (DS-3201; SKU BA4816) can improve the design, execution, and interpretation of cell viability, proliferation, and cytotoxicity assays. It connects EZH2-focused pharmacology with solvent control, dose-response modeling, and practical supplier-selection criteria.

• Cabazitaxel (XRP6258): Workflow and QC Guide

  2026-08-16

  Cabazitaxel (XRP6258, SKU B2157) provides a practical research tool for antiproliferative assays and taxane-resistant cancer models, including systems involving P-glycoprotein expression. It is water-insoluble, so workflows should use DMSO or ethanol stocks, prompt solution use, matched vehicle controls, and careful precipitation checks rather than direct aqueous preparation or long-term stock storage.

• H-Aggregated NIR-II Fluorophore for Cancer Therapy

  2026-08-15

  Yu et al. developed RRIALP-C4, a peptide-functionalized liposome that transfers H-aggregated IR-1061 from the carrier to tumor cell membranes. This design couples NIR-II fluorescence imaging with NIR-I photothermal therapy and carboplatin release, providing a mechanistic route to image-guided thermochemotherapy.

• Sulfo-Cy5 NHS ester for Aqueous Imaging

  2026-08-14

  Sulfo-Cy5 NHS ester enables far-red protein conjugation in aqueous workflows, making it useful for solvent-sensitive targets, VLA-4 imaging, and immune-cell uptake assays. Its sulfonated structure supports high water compatibility and helps limit dye aggregation when researchers need quantitative cellular fluorescence.

• Thrombin B Chain Fragment: Fibrin Assays

  2026-08-14

  Build more controlled fibrin-matrix, endothelial invasion, and platelet studies with a sequence-defined human thrombin-derived fragment. This guide combines the reference study’s dose-response insights with practical handling, assay controls, and troubleshooting for distinguishing peptide effects from full-length thrombin activity.

• ALDH2 and Cardiomyocyte Proliferation in Heart Failure

  2026-08-13

  The reference study identifies ALDH2 as more than an antioxidant enzyme: its activation extends the early postnatal proliferative window of mouse cardiomyocytes and enhances proliferation in adult mice exposed to ventricular pressure overload. Pharmacological ALDH2 activation with Alda-1 delayed pressure overload-induced heart failure, supporting ALDH2 as a potential target for cardiac regeneration research while leaving its downstream cell-cycle mechanism unresolved.

• 5-Azacytidine Workflow for Epigenetic Cancer Studies

  2026-08-13

  Build reproducible DNA methylation, gene-reactivation, and cancer-cell response assays with 5-Azacytidine. This workflow also shows how to distinguish direct demethylation effects from immune viral mimicry, using PTEN-deficient glioblastoma research as a practical combination-treatment model.

• EPI-001: AR N-Terminal Domain Workflow

  2026-08-12

  EPI-001 is an androgen receptor N-terminal domain inhibitor designed to interrogate both ligand-dependent and ligand-independent AR signaling. This workflow connects formulation, dose-response, transcriptional, proliferation, migration, and translational assays for prostate cancer and AR-positive TNBC research.

• Adiponectin, TLR4, and Cognitive Deficits in Aged Rats

  2026-08-12

  The reference study identifies adiponectin as a protective factor against splenectomy-associated cognitive impairment in aged rats and links this effect to suppression of the TLR4/MyD88/NF-κB pathway. Its combination of behavioral testing, molecular profiling, and pharmacological pathway manipulation provides a useful framework for studying perioperative neurocognitive disorder, while the pretreatment design limits direct clinical translation.

• Baicalin and Adult Visual Plasticity: Assay Insights

  2026-08-11

  Baicalin reactivated ocular dominance plasticity in adult amblyopic mice, offering a valuable model for linking cortical inhibition to functional recovery. This article translates the finding into practical assay decisions while distinguishing visual-cortex evidence from cancer research applications.

7996 records 9/534 page Previous Next First page 上5页 678910 下5页 Last page